Protagonist Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
PTGX
CUSIP
74366E102
Type
Equity
Class
COM
Num filings
196
Total reported value, excl. options
$1.85 B
Manager Report Date Value ($000) Shares Option Type